| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/21/2002 | US20020022003 Method and composition for the treatment of cancer by the enzymantic conversion of soluble radioactive toxic precipitates in the cancer |
| 02/21/2002 | DE10111224A1 Analoge der Ecstasy-Klasse sowie Verwendung derselben beim Nachweis von Verbindungen der Ecstasy-Klasse Analog ecstasy-class and use thereof in the detection of compounds of ecstasy-class |
| 02/21/2002 | DE10036671A1 New nucleic acid encoding mitochondrial transporter, useful for preparing transgenic plants with e.g. altered protein content and improved germination |
| 02/21/2002 | DE10035292A1 Verfahren zur Gewinnung von Proteinen aus Pflanzen in reiner Form A process for the recovery of proteins from plant in pure form |
| 02/21/2002 | CA2419725A1 Genes involved in immune related responses observed with asthma |
| 02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | CA2419133A1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417152A1 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/21/2002 | CA2416898A1 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | CA2415353A1 Use of antibodies against specific mhc-peptide complexes |
| 02/20/2002 | EP1180687A1 Method and in vitro kit for selecting a drug for chemotherapy |
| 02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
| 02/20/2002 | EP1180369A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180147A1 Secreted alpha-helical protein-31 |
| 02/20/2002 | EP1180146A1 Secreted alpha-helical protein - 32 |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180123A1 Immunoconjugates having high binding affinity |
| 02/20/2002 | EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 02/20/2002 | EP1180118A1 Fimbrial proteins |
| 02/20/2002 | EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 02/20/2002 | EP0728215B1 METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE |
| 02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348581 High affinity humanized anti-TAG-72 monoclonalantibodies |
| 02/19/2002 | US6348580 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348577 Regulation of aureobasidin sensitivity in fungus |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348571 Corticotropin release inhibiting factor and methods of using same |
| 02/19/2002 | US6348569 Spruce budworm antifreeze proteins, genes and method of using same |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348344 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 02/19/2002 | US6348342 Compounds |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348334 DNA encoding Fas ligand |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348320 Contacting serum sample with antibody which binds to specified crosslinked peptide, detecting binding of antibody, correlating any detected binding to resorption of unmineralized type ii collagen in vivo |
| 02/19/2002 | US6348318 Kit comprising target analyte binding moiety, magnetically responsive particles to which are attached capture moieties capable of reversibly binding target analyte binding moiety, detection moiety capable of binding to target binding moiety |
| 02/19/2002 | US6348315 Polysome display in the absence of functional ssrA-RNA |
| 02/19/2002 | US6348194 Tumor specific internalizing antigens and methods for targeting therapeutic agents |
| 02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
| 02/19/2002 | CA2085953C Human antithrombin-iii preparation |
| 02/19/2002 | CA2039387C Heat-treated igm antibody preparations |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/14/2002 | WO2002012535A1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy |
| 02/14/2002 | WO2002012528A2 Enhanced 2-keto-l-gulonic acid production |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012481A2 Enhancement of industrial production by increasing substrate transport |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012468A2 2,5-dkg permeases |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | WO2002012437A2 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | WO2002012347A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | WO2002012346A2 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | WO2002012345A2 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012284A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 02/14/2002 | WO2002012279A2 Schizophrenia related gene and protein |
| 02/14/2002 | WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | WO2002012272A2 Therapeutic anti-melanoma compounds |
| 02/14/2002 | WO2002011767A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 02/14/2002 | WO2002011763A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 02/14/2002 | WO2002011762A2 Methods and compositions for modulating tumor growth |
| 02/14/2002 | WO2002011757A2 Compositions and methods for inhibiting transmission of malaria |
| 02/14/2002 | WO2002011743A2 Treatment of prostate cancer |
| 02/14/2002 | WO2002011667A2 Pharmaceutical compositions and methods useful for modulating angiogenesis |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001070766A3 Therapeutic anti-cytomegalovirus compounds |
| 02/14/2002 | WO2001064247A3 Method of treating cancer with anti-neurotrophin agents |
| 02/14/2002 | WO2001062954A8 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001055302A3 Nucleic acids, proteins, and antibodies |
| 02/14/2002 | WO2001048161A3 Human heparanase-related polypeptide and nucleic acid |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001036589A3 Human ex vivo immune system |